Evidence map›Paper›PMID 21811775›Full record

ArticleJournal of molecular modeling2012

Conformational flexibility, binding energy, role of salt bridge and alanine-mutagenesis for c-Abl kinase complex.

Kshatresh Dutta Dubey, Rajendra Prasad Ojha

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kshatresh Dutta DubeyDepartment of Physics, DDU Gorakhpur University, Gorakhpur, India. kshatresh@gmail.com
Rajendra Prasad Ojha

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abl kinase plays a decisive role in the mechanism of the most fatal human pathogen chronic mylogenous leukemia (CML). Here, we have carried out a comprehensive study about the conformational flexibility, role of salt bridge and the protein- ligand interaction for this kinase with its well-known inhibitor, Imatinib. We have performed molecular dynamics simulations for conformational behavior, investigated the salt bridges and calculated the binding free energy of Imatinib with MM-PB/SA method for Abl kinase complex. We also explored the role of salt-bridge in the kinase complex and its effect on binding activity of inhibitors. Furthermore, to investigate the importance of those residues which form salt bridges, we mutated them by Alanine with the help of Alanine scanning program. We noticed significant variations in total free energy of Imatinib in all possible mutations. The binding free energy of ligand for kinase receptor was analyzed by molecular mechanics Poission Boltzmann surface area (MM-PB/SA) method. These results suggest that conserved glutamic acid and lysine are necessary for stability of complex.

Indexed as

AlanineBenzamidesBinding SitesGlutamic AcidHumansHydrogen BondingImatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLigandsLysineMolecular Dynamics SimulationMutagenesisPiperazinesProtein BindingProtein ConformationProtein Kinase InhibitorsAlanineBenzamidesGlutamic AcidImatinib MesylateLigandsLysinePiperazinesProtein Kinase InhibitorsProto-Oncogene Proteins c-ablPyrimidinesSalts

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.